LakeShore Biopharma Stock Forward View
| LSBCF Stock | 0.40 0.45 52.94% |
LakeShore Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of LakeShore Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 7th of February 2026 the rsi of LakeShore Biopharma's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using LakeShore Biopharma hype-based prediction, you can estimate the value of LakeShore Biopharma Co from the perspective of LakeShore Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of LakeShore Biopharma Co on the next trading day is expected to be 0.39 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.65. LakeShore Biopharma after-hype prediction price | USD 0.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
LakeShore | Build AI portfolio with LakeShore Stock |
LakeShore Biopharma Additional Predictive Modules
Most predictive techniques to examine LakeShore price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LakeShore using various technical indicators. When you analyze LakeShore charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
LakeShore Biopharma Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the LakeShore Biopharma's financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2010-12-31 | Previous Quarter 25.3 M | Current Value 24 M | Quarterly Volatility 142 M |
LakeShore Biopharma Naive Prediction Price Forecast For the 8th of February
Given 90 days horizon, the Naive Prediction forecasted value of LakeShore Biopharma Co on the next trading day is expected to be 0.39 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.65.Please note that although there have been many attempts to predict LakeShore Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that LakeShore Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
LakeShore Biopharma Stock Forecast Pattern
| Backtest LakeShore Biopharma | LakeShore Biopharma Price Prediction | Research Analysis |
LakeShore Biopharma Forecasted Value
In the context of forecasting LakeShore Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. LakeShore Biopharma's downside and upside margins for the forecasting period are 0 and 7.25, respectively. We have considered LakeShore Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of LakeShore Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent LakeShore Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.9532 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0271 |
| MAPE | Mean absolute percentage error | 0.0381 |
| SAE | Sum of the absolute errors | 1.6528 |
Predictive Modules for LakeShore Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma After-Hype Price Density Analysis
As far as predicting the price of LakeShore Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LakeShore Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LakeShore Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
LakeShore Biopharma Estimiated After-Hype Price Volatility
In the context of predicting LakeShore Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LakeShore Biopharma's historical news coverage. LakeShore Biopharma's after-hype downside and upside margins for the prediction period are 0.02 and 7.26, respectively. We have considered LakeShore Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
LakeShore Biopharma is out of control at this time. Analysis and calculation of next after-hype price of LakeShore Biopharma is based on 3 months time horizon.
LakeShore Biopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as LakeShore Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LakeShore Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LakeShore Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.88 | 6.86 | 0.00 | 0.00 | 6 Events / Month | 0 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.40 | 0.40 | 0.00 |
|
LakeShore Biopharma Hype Timeline
LakeShore Biopharma is now traded for 0.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. LakeShore is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.88%. %. The volatility of related hype on LakeShore Biopharma is about 0.0%, with the expected price after the next announcement by competition of 0.40. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in about 6 days. Check out Historical Fundamental Analysis of LakeShore Biopharma to cross-verify your projections.LakeShore Biopharma Related Hype Analysis
Having access to credible news sources related to LakeShore Biopharma's direct competition is more important than ever and may enhance your ability to predict LakeShore Biopharma's future price movements. Getting to know how LakeShore Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LakeShore Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IGXT | Intelgenx Technologs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMMPF | ImmuPharma Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ACOGF | Alpha Cognition | 0.00 | 0 per month | 0.00 | (0.06) | 9.94 | (9.30) | 65.10 | |
| KMSTF | Kadimastem | 0.00 | 0 per month | 0.00 | (0.17) | 10.12 | (14.40) | 39.40 | |
| EMMLF | OKYO Pharma Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IBXNF | IBEX Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DMTTF | Small Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OCEL | Ocean Electric | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PMXSF | Pharmaxis | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RLFTD | Relief Therapeutics Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for LakeShore Biopharma
For every potential investor in LakeShore, whether a beginner or expert, LakeShore Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. LakeShore Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in LakeShore. Basic forecasting techniques help filter out the noise by identifying LakeShore Biopharma's price trends.LakeShore Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LakeShore Biopharma stock to make a market-neutral strategy. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
LakeShore Biopharma Market Strength Events
Market strength indicators help investors to evaluate how LakeShore Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LakeShore Biopharma shares will generate the highest return on investment. By undertsting and applying LakeShore Biopharma stock market strength indicators, traders can identify LakeShore Biopharma Co entry and exit signals to maximize returns.
LakeShore Biopharma Risk Indicators
The analysis of LakeShore Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in LakeShore Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lakeshore stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.94 | |||
| Standard Deviation | 6.81 | |||
| Variance | 46.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for LakeShore Biopharma
The number of cover stories for LakeShore Biopharma depends on current market conditions and LakeShore Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that LakeShore Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about LakeShore Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
LakeShore Biopharma Short Properties
LakeShore Biopharma's future price predictability will typically decrease when LakeShore Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of LakeShore Biopharma Co often depends not only on the future outlook of the potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.9 M | |
| Cash And Short Term Investments | 28.1 M |
Check out Historical Fundamental Analysis of LakeShore Biopharma to cross-verify your projections. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.